MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Access to rehabilitation therapy for people with Parkinson’s disease in Rome, Italy

    G. Di Lazzaro, D. Genovese, AT. Cimmino, P. Zinzi, AR. Bentivoglio, P. Calabresi (Rome, Italy)

    Objective: This survey aimed to evaluate patients’ awareness of healthcare roles, access to care, and use of rehabilitation services in the Rome region, Italy. Background:…
  • 2026 International Congress

    Diffusion MRI Evidence of Cerebellar Involvement in Cognitive Dysfunction in Parkinson’s Disease

    A. Vijayakumari, L. Saadatpour, D. Floden, K. Sakaie, H. Kaur, H. Fernandez, B. Walter (Cleveland, USA)

    Objective: To determine whether cerebellar axonal microstructural abnormality is associated with cognitive performance in PD. Background: Cognitive impairment in Parkinson’s disease (PD) often affects executive…
  • 2026 International Congress

    Clinical Markers of Monogenic Mimics in Atypical Parkinsonism: Findings From a 150-Patient Series

    ZD. Cen, YX. Kang, XH. Chen, B. Wang, W. Luo (Zhejiang, China)

    Objective: We aimed to (1) define the yield and spectrum of genetic findings in an unselected Atypical Parkinsonism (AP)  series and (2) identify clinical markers…
  • 2026 International Congress

    Increased Pre-Alpha EEG Functional Connectivity Forecasts Future Cognitive Decline in Parkinson’s Disease

    A. Tetereva, G. Hall-Mcmaster, N. Slater, A. Harris, R. Shoorangiz, C. Le Heron, R. Keenan, I. Kirk, W. Meissner, T. Anderson, T. Melzer, N. Pat, J. Dalrymple-Alford (Christchurch, New Zealand)

    Objective: To evaluate whether resting-state EEG functional connectivity (rsEEG-FC) forecasts cognitive decline three years later in Parkinson’s disease (PD). Background: Cognitive performance and trajectories of…
  • 2026 International Congress

    Physical Activity is Associated with Attenuated Motor and Cognitive Progression in Parkinson’s Disease

    DW. Ryu, KR. Duque, J. Abanto, L. Marsili, NC. Paredes, AH. Gorriti, H. Deraz, E. Hill, A. Duker, AJ. Espay (Seoul, Republic of Korea)

    Objective: To determine whether physical activity (PA) modifies the rate of motor and cognitive progression in Parkinson’s disease (PD) and to identify specific components of…
  • 2026 International Congress

    Impact of Alpha-Synuclein Burden and Cellular Stress on GBA-PD Macrophage

    V. Lentini, G. Uras, D. Moreno-Martinez, S. Lucas, A. Pantaleo, D. Hughes (London, United Kingdom)

    Objective: This study explores how non-neuronal dysfunction drives the rapid progression of GBA-PD, aiming to identify therapeutic targets that restore protein degradation and cellular stability.…
  • 2026 International Congress

    Image-Guided DBS Programming in Dystonia: Experience from a Tertiary Public Brazilian Center

    M. Soares, J. Nogueira, J. Gomes, M. Bezerra (Recife, Brazil)

    Objective: To illustrate the clinical utility of postoperative DBS lead reconstruction and image-guided programming in genetic dystonia Background: DBS of the globus pallidus internus (GPi)…
  • 2026 International Congress

    5-year Longitudinal Changes in Non-motor Symptoms and Their Association With Motor Progression in Parkinson’s Disease

    S. Heinzel, Q. Destani-Dauti, M. Hobert, W. Maetzler, D. Berg (Kiel, Germany)

    Objective: To examine longitudinal relationships between non-motor symptoms (NMS) and motor progression in Parkinson’s disease (PD), and to determine whether baseline NMS predict motor decline…
  • 2026 International Congress

    Investigating the Role of Biallelic EPG5 Variants in Parkinson’s Disease

    R. Torricelli, G. Cogan, B. Bustos, C. Tesson, T. Abramova, I. Keller Sarmiento, A. Hejnusova, V. Quintana Pena, A. Tan, T. Ong, S. Lim, H. Morris, J. Frost, C. Pinon, S. Lesage, A. Noyce, M. Periñan, J. Trinh, A. Brice, N. Mencacci (London, United Kingdom)

    Objective: Investigate EPG5 role in PD aetiology. Background: Disruption of the lysosome-autophagy pathway is a recurrent feature in Parkinson’s disease (PD). EPG5 bi-allelic loss-of-function variants have been…
  • 2026 International Congress

    Non‑Motor Outcomes after STN-FUS for Parkinson’s disease

    E. Natera-Villalba, R. Rodríguez-Rojas, JA. Pineda-Pardo, T. Jimenez-Castellanos, M. Del Alamo, M. Escribano, D. Mata Marín, P. Guida, I. Obeso, JA. Obeso, R. Martínez-Fernández (Madrid, Spain)

    Objective: To assess changes in non-motor symptoms(NMS) in PD after focused ultrasound subthalamotomy(STN-FUS). Background: NMS impair quality of life in PD.STN-FUS improves motor signs in PD but…
  • « Previous Page
  • 1
  • …
  • 67
  • 68
  • 69
  • 70
  • 71
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley